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Abstract 
 
In this Special Issue on “Nutraceuticals: Molecular and Functional Insights into how Natural 
Products Nourish the Brain”, the editors bring together contributions from experts in 
nutraceutical research to provide a contemporary overview of how select chemically 
identified molecules from natural products can beneficially affect brain function at the 
molecular level. Other contributions address key emergent issues such as bioavailability, 
neuronal health, inflammation and the holistic benefit of multi-targeted actions that impact 
upon how nutraceuticals ultimately leverage the brain to function better. In terms of the 
benefit of nutraceuticals it is clear that some naturally occurring molecules can be 
advantageous to both the young and aged brain, and that they have actions that ultimately can 
be directed to aid either in the improvement of cognition or in the management of debilitating 
neurodegenerative and neuropsychiatric conditions. 
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Welcome to the second volume in this initiative “Nutraceuticals: Molecular and Functional 
Insights into how Natural Products Nourish the Brain”. Readers are referred to the first 
volume published in Neurochemistry International 89, 1-280 (2015). The term Nutraceutical 
was introduced in 1989 by Dr. Stephen L. De Felice (Founder and Chairman of the 
Foundation for Innovation in Medicine, New Jersey, USA) from nutrition and 
pharmaceutical. Whilst a key aim herein was to focus on investigations of chemically 
identified molecules isolated from traditional medicines, a further aim was to overview the 
background and modern horizons of how nutraceuticals might be used to sustain brain health 
in daily life and during debilitating pathologies. The first volume also addressed some aspects 
of the limitations to the exploitation of nutraceuticals and sought to give some proper 
consideration to the metabolism, bioavailability and blood brain permeability of molecules 
that might exert beneficial actions on brain. Overall this volume engendered considerable 
enthusiasm amongst people interested in links between nutraceuticals and the healthy brain. 
Indeed the Editorial, “Neuro-nutraceuticals: The path to brain health via nourishment is not 
so distant”, which covered broadly historical perspectives, multi-targeting, regulatory issues 
and highlighted key advances therein (Williams et al., 2015), has been downloaded over 900 
times in 2015. The second volume contains unique insights into still more molecules and 
adds new perspectives to how nutraceuticals should be viewed. The editors in assembling this 
Special Issue, “Nutraceuticals: Molecular and Functional Insights into how Natural Products 
Nourish the Brain”, recognized that the time was right for an overview of this expanding 
field. Overall, we hoped this Special Issue would provide a timely overview of this emerging 
field and map key future directions for neuro-nutraceutical research. The coverage provided 
will be of broad interest not only to academic and commercial researchers, and students, but 
also to the enormous numbers in the community who seek to keep their brains healthy by the 
use of natural products. 
 
1. Further insights into the actions of nutraceuticals 
 
One of the goals of this Special Issue was to document the latest advances relevant to natural 
products where the active principles had been identified and especially where workers in the 
field were attempting to describe actions at defined targets relevant to the healthy brain and 
crippling pathologies. Dietary intake of creatine continues to attract much interest - indeed 
its increased intake can elevate brain creatine, preserve cognitive function under stress and its 
consumption has thus been assessed in several adult neurodegenerative conditions since it 
directly preserves mitochondrial function (Rae and Bröer, 2015). New data reported herein 
indicate that creatine exerts protective actions against oxidative and nitrosative stress induced 
in SH-SY5Y cells by L-glutamate, and appears to exert similar beneficial effects in vivo in 
brain when chronically but not acutely administered (Cunha et al.). Further, dietary creatine 
supplementation during pregnancy may be an effective prophylaxis that can protect the foetus 
from the multi-organ consequences of severe hypoxia at birth where neonatal brain injury 
ensues subsequent to mitochondrial energy failure and reduced ATP production (Ellery et 
al.). Eugenol (contained in Syzygium aromaticum, clove oil and leaves) enhanced the 
viability of SH-SY5Y cells by ameliorating oxidative stress in experimental hyperglycemia. 
Additionally, eugenol treatment of diabetic rats resulted in diminution in brain of oxidative 
markers and protein carbonyls in both cytosolic and mitochondrial fractions, with restoration 
of activities of mitochondrial complexes I, II and III (Prasad et al.). This naturally occurring 
polyphenol has a long history of use in Ayurvedic practices as an antiseptic, carminative and 
analgesic for dental problems, and thus seems worthy of consideration as an adjuvant 
therapeutic molecule to alleviate complications under diabetic conditions. Curcumin, the 
most abundant phenolic compound in turmeric (Curcuma longa), has been used extensively 
in Asian countries for its health-promoting effects. Its loading into lactoferrin nanoparticles 
provides a 3-4 fold increase in the effective concentration of curcumin achieved leading to 
significantly greater improvements in viability and reductions in α-synuclein relative to 
soluble curcumin in the neuroblastoma SK-N-SH dopaminergic cell line (Bollimpelli et al.). 
These findings reinforce the report in our first volume that modern drug delivery approaches 
improve the bioavailability and effectiveness of curcumin (Hagl et al., 2015). 
 
2. Nutraceuticals as anti-inflammatory agents 
 
Inflammation in neuropathologies is now a huge topic of study internationally with innate 
and adaptive immunity well established and cross-talk between the nervous and immune 
systems fully accepted. Macrophages are known to invade the brain and interface with the 
brain’s resident inflammatory cells, microglia and astrocytes. The phenotypes of these 
inflammatory cells in the injured or diseased brain are the centre of great contemporary 
interest as they may be targets where nutraceuticals could act beneficially. We refer readers 
to earlier published work in the first volume where oxymatrine (Zhao et al., 2015), apocynin 
(Lee et al., 2015), curcumin (Kaur et al., 2015) and allyl cysteine (Colín-González et al., 
2015) were all reported to have anti-inflammatory actions. 
 Resveratrol (found in grapes, red wine, mulberries, peanuts and various plants), a much 
studied stilbene, is known to dampen peripheral inflammation. Resveratrol penetrates the 
blood brain barrier, and Steiner et al. investigated its effects on a broad range of pro- and 
anti-inflammatory factors. They report that resveratrol, at concentrations found in plasma, 
effectively reduced pro-inflammatory cytokines in activated macrophage and microglial cell 
lines highlighting its broad anti-inflammatory effects and likely benefits during 
neuroinflammation. These new insights, when taken with findings in our first volume (Lopez 
et al., 2015), complement existent evidence on the neuroprotective potential of resveratrol, 
which is relatively well tolerated in clinical trials, and allows the brain to maintain 
homeostasis minimizing age-related behavioural decline (Poulose et al., 2015). Marine 
microorganisms also represent promising sources of metabolites with bioactivity, and Cho et 
al. examined the actions of citreohybridonol isolated from marine-derived fungal strain 
Toxicocladosporium sp.. Their findings suggest that citreohybridonol has anti-
neuroinflammatory effects suppressing the production of pro-inflammatory mediators and 
cytokines, including TNF-α, IL-1β, IL-12, IL-6, iNOS, and COX-2, in activated BV2 
cells. This action focuses attention on citreohybridonol and related terpenoid derivatives for 
the development of anti-inflammatory treatment of pathologies where neuroinflammation 
has been documented. 
 
Venigalla et al. in a timely review analyse existent findings on a select group of 
nutraceuticals: curcumin, apigenin, (-) epigallocatechin-3-gallate (EGCG), 
docosahexaenoic acid, α-lipoic acid and resveratrol. Importantly when considering anti-
inflammatory and neuroprotective actions they delineate comprehensively the suitability of 
all molecules from the perspectives of pharmacokinetics, safety, mechanistic pathways and 
cellular studies, animal studies and human studies. The authors make the most interesting 
point that treatments appear more effective when initiated early in the disease and conclude 
that careful prospective studies are needed with these molecules in patients with mild 
cognitive impairment or in early stages of Alzheimer’s disease. We refer readers to pertinent 
articles in the first volume of this Special Issue where informative and relevant background is 
provided on curcumin (Hagl et al., 2015; Kaur et al., 2015; Murugaiyah and Mattson, 2015), 
EGCG (Dutta and Mohanakumar, 2015), docosahexaenoic acid (Vauzour et al., 2015) and 
resveratrol (Poulose et al., 2015). Short Chain Fatty Acids, medium Chain Fatty Acids 
(MCFA) and long Chain fatty acids (LCFA) have different functions and effects on brain, 
often conferring some degree of neuroprotection through a variety of mechanisms, and 
represent potential treatments for a wide range of neurological and psychiatric disorders (Lei 
et al.). Here MCFAs and LCFAs both appear more beneficial - MCFAs because they 
represent alternative energy sources and have anti-inflammatory actions, whereas LCFAs are 
highly anti-inflammatory, contribute to membrane fluidity and their levels may be linked to 
cognitive function. Of course, docosahexaenoic acid is the most studied and appears to be 
neuroprotective in various forms of brain injury, including traumatic brain injury and 
ischaemia. Flavonoids also receive attention in the context of neuroinflammation - as 
discussed in the first volume, flavonoids have moved from being considered purely as anti-
oxidants through actions as free radical scavengers to a position where they have diverse 
actions, including on many signalling cascades, some of which influence cellular survival 
mechanisms and blood flow (Williams et al., 2015). Matias and colleagues offer a rather 
different focus upon the role of astrocytes as mediators of polyphenol action in brain and how 
these glial cells might underpin beneficial actions in brain pathologies. They identify 
inhibition of astrogliosis, and improved anti-oxidant response and secretion of 
neuroprotective soluble factors as likely key responses of these resident inflammatory cells. 
 
3. Dietary supplements: benefits of multi-target approaches 
 
There is frequent mention in the literature of the concept that interactions among various 
classes of chemicals present in foods may contribute to their potent “nutraceutical actions”. 
Here Sinha et al. provide a very relevant demonstration of the effectiveness of a nutraceutical 
“cocktail”. Long-term dietary supplementation of rats with a combination of N-
acetylcysteine, α-lipoic and α-tocopherol from 18 months onwards daily till their sacrifice 
at 22-24 months attenuated the age-related alterations in β-amyloid metabolism. This dietary 
regimen remarkably prevented impairment of spatial learning and memory in aged rats. 
Moreover, doses employed here were chosen with reference to recommended dietary 
allowances. Whilst this targeted application is not exactly herbal medicine, one cannot help 
but be impressed with the effectiveness of this carefully chosen neuro-nutraceutical mix 
which harks back to the bandied expression “the whole is more than the sum of its parts” 
(Joseph et al., 1998). This concept is further elaborated by Solanki et al., who discuss herbal 
medicines and focus on the beneficial properties of flavonoids (e.g. fistein, quercetin, 7,8-
dihydroxyflavone), especially their applications for intervention and in amelioration of injury 
in various neurodegenerative diseases. As potential dietary supplements their multi-target 
properties may be beneficial in prevention and treatment of the age-associated 
neurodegenerative diseases (Williams et al., 2015). Neurobiological perspectives on some 
individual flavonoids can be found in the first volume of this Special Issue (Blasina et al., 
2015; Dajas et al., 2015; Du and Hill, 2015; Johnston, 2015; Krasieva et al., 2015). Wadhwa 
et al. also contextualise the holistic, multifunctional drug/multi-target approach which may 
alleviate the diverse pathological consequences inflicted by the multifactorial nature of brain 
disorders. These authors review the actions of Ashwagandha (Withania somnifera), 
extensively employed in traditional medicines (Kataria et al., 2015), which enhances the 
body's resilience to stress. 
 
4. Nutraceuticals and their promise 
 
The articles in “Nutraceuticals: Molecular and Functional Insights into how Natural Products 
Nourish the Brain” reflect the topic’s dynamic nature and the enthusiasm of authors for this 
rapidly expanding field. When this Special Issue was planned it was never imagined that it 
would grow to 39 articles across two volumes, but the number of contributors reflects the 
vibrancy of ongoing work across different problems, and their internationality demonstrates 
its global relevance to health and therapeutics. Many natural products used in traditional 
medicine have been known for centuries to exert beneficial actions on diverse brain functions 
and often the active principles have been identified, so potentially their application under 
appropriately regulated conditions to aid in the management of debilitating neurodegenerative 
and psychiatric conditions could occur in the not too distant future.  
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